Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China · Delayed Price · Currency is CNY 32.20
+0.72 (2.29%)
At close: Feb 6, 2026
SHE:002422 Revenue
Sichuan Kelun Pharmaceutical had revenue of 4.19B CNY in the quarter ending September 30, 2025, a decrease of -15.48%. This brings the company's revenue in the last twelve months to 18.30B, down -18.66% year-over-year. In the year 2024, Sichuan Kelun Pharmaceutical had annual revenue of 21.81B with 1.67% growth.
Revenue (ttm)
18.30B
Revenue Growth
-18.66%
P/S Ratio
2.80
Revenue / Employee
837.01K
Employees
21,864
Market Cap
51.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.81B | 358.49M | 1.67% |
| Dec 31, 2023 | 21.45B | 2.42B | 12.69% |
| Jan 1, 2023 | 19.04B | 1.76B | 10.19% |
| Jan 1, 2022 | 17.28B | 813.21M | 4.94% |
| Dec 31, 2020 | 16.46B | -1.17B | -6.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 53.89B |
| Zhejiang Int'l Group | 33.54B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yifan Pharmaceutical | 5.22B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 2.81B |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.05B |
| Shanghai InnoStar Bio-tech | 829.92M |
Sichuan Kelun Pharmaceutical News
- 2 months ago - Crescent, Kelun-Biotech Sign Oncology Deal; Crescent To Raise $185 Mln; Stock Up - Nasdaq